Chan Shin Mei, Cornman-Homonoff Joshua, Lucatelli Pierleone, Madoff David C
Department of Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA; Department of Radiology and Biomedical Imaging, Section of Interventional Radiology, Yale School of Medicine, New Haven, CT, USA.
Department of Radiology and Biomedical Imaging, Section of Interventional Radiology, Yale School of Medicine, New Haven, CT, USA.
Clin Imaging. 2024 Jul;111:110185. doi: 10.1016/j.clinimag.2024.110185. Epub 2024 May 13.
Despite considerable advances in surgical technique, many patients with hepatic malignancies are not operative candidates due to projected inadequate hepatic function following resection. Consequently, the size of the future liver remnant (FLR) is an essential consideration when predicting a patient's likelihood of liver insufficiency following hepatectomy. Since its initial description 30 years ago, portal vein embolization has become the standard of care for augmenting the size and function of the FLR preoperatively. However, new minimally invasive techniques have been developed to improve surgical candidacy, chief among them liver venous deprivation and radiation lobectomy. The purpose of this review is to discuss the status of preoperative liver augmentation prior to resection of hepatocellular carcinoma with a focus on these three techniques, highlighting the distinctions between them and suggesting directions for future investigation.
尽管手术技术取得了长足进步,但许多肝恶性肿瘤患者由于预计切除术后肝功能不足而不适合手术。因此,在预测肝切除术后患者发生肝衰竭的可能性时,未来肝残余量(FLR)的大小是一个重要的考虑因素。自30年前首次描述以来,门静脉栓塞已成为术前增加FLR大小和功能的标准治疗方法。然而,已经开发出了新的微创技术来改善手术适应证,其中主要包括肝静脉阻断和放射叶切除术。本综述的目的是讨论肝细胞癌切除术前肝脏增大的现状,重点关注这三种技术,突出它们之间的区别,并为未来的研究提出方向。